RM
Robert McNamara

Robert McNamara insider trades: AVITA Medical (RCEL) stock buys and sales

AVITA Medical Last trade Aug 28, 2025 40 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
11
Open-market trades
since 2014
6
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Robert reports to the SEC

Open-market buys and sales

11 trades reported on SEC Form 4, newest first

DateStockTypeValue
Aug 28, 2025RCEL↑ Buy$45K
Aug 19, 2025RCEL↑ Buy$50K
Mar 6, 2025RCEL↑ Buy$91K
Feb 20, 2025RCEL↑ Buy$101K
Nov 10, 2015LDRH↓ Sell$507K
May 11, 2015LDRH↓ Sell$650K
Mar 13, 2015LDRH↓ Sell$316K
Mar 3, 2015LDRH↓ Sell$195K
Dec 11, 2014LDRH↓ Sell$178K
Aug 15, 2014LDRH↓ Sell$544K
Jun 16, 2014LDRH↓ Sell$986K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RCEL insiders

Open-market trades in the last 12 months

About Robert McNamara's insider trades

Robert McNamara is an insider at AVITA Medical (RCEL). Since Jun 16, 2014, Robert has reported 4 open-market purchases worth $287K and 7 sales worth $3.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (25 filings), option exercises (10 filings), shares returned to the company (4 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RCEL insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.